Researchers at Florida Atlantic University’s Brain Institute are working on an experimental drug that shows potential in treating the core symptoms of autism in adults.
Currently, there are no FDA-approved medications for adults with autism, leading to frustration among patients and their families.
Dr. Randy Blakely and his team have discovered a molecular pathway in the brain that may help control mood disorders associated with autism. Initial studies on mice have shown promising results, improving social interactions and reducing repetitive behaviors.
While the drug is currently in the early stages of clinical trials for a different indication, the researchers aim to advance to clinical trials specifically for autism in the future. The research is funded by the National Institute of Mental Health.
